90 related articles for article (PubMed ID: 10375757)
1. Use of caffeine as a probe for rapid determination of cytochrome P-450 CYP1A2 activity in humans.
Ou-Yang DS; Huang SL; Xie HG; Wang CY; Zhou HH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):44-6. PubMed ID: 10375757
[TBL] [Abstract][Full Text] [Related]
2. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
[TBL] [Abstract][Full Text] [Related]
3. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
Perera V; Gross AS; McLachlan AJ
Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
[TBL] [Abstract][Full Text] [Related]
4. [HPLC determination of five caffeine metabolites].
Lu JF; Yi T; Cao XM; Zhuo HT; Lin SS
Yao Xue Xue Bao; 1997 Aug; 32(8):607-11. PubMed ID: 11596311
[TBL] [Abstract][Full Text] [Related]
5. [Determination of salbutamol in human plasma by column-switching HPLC with UV detection].
Qin Y; Zou Y; Liang M; Yu Q; Huang Y; Li T; Xu X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):576-9. PubMed ID: 12910727
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.
Carrillo JA; Christensen M; Ramos SI; Alm C; Dahl ML; Benitez J; Bertilsson L
Ther Drug Monit; 2000 Aug; 22(4):409-17. PubMed ID: 10942180
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.
Begas E; Kouvaras E; Tsakalof AK; Bounitsi M; Asprodini EK
Biomed Chromatogr; 2015 Nov; 29(11):1657-63. PubMed ID: 25891161
[TBL] [Abstract][Full Text] [Related]
8. Solid-liquid extraction and cation-exchange solid-phase extraction using a mixed-mode polymeric sorbent of Datura and related alkaloids.
Mroczek T; Głowniak K; Kowalska J
J Chromatogr A; 2006 Feb; 1107(1-2):9-18. PubMed ID: 16388811
[TBL] [Abstract][Full Text] [Related]
9. Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.
Yin OQ; Lam SS; Lo CM; Chow MS
Rapid Commun Mass Spectrom; 2004; 18(23):2921-33. PubMed ID: 15529418
[TBL] [Abstract][Full Text] [Related]
10. Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure.
Alarcan H; Cannet P; Camus V; Fond G; Zendjidjian X; Guilhaumou R; Quaranta S
Br J Clin Pharmacol; 2023 May; 89(5):1665-1671. PubMed ID: 36507652
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
Krul C; Hageman G
J Chromatogr B Biomed Sci Appl; 1998 May; 709(1):27-34. PubMed ID: 9653923
[TBL] [Abstract][Full Text] [Related]
12. Assay of metoprolol and alpha-hydroxymetoprolol in human urine by reversed-phase liquid chromatography with direct-injection.
Xie HG; Zhou HH
Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):32-5. PubMed ID: 7771192
[TBL] [Abstract][Full Text] [Related]
13. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
Tang BK; Zhou Y; Kadar D; Kalow W
Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
[TBL] [Abstract][Full Text] [Related]
14. [Determination of catechins and caffeine in tea and tea beverages by high-performance liquid chromatography].
Ling Y; Zhao YF; Li ZJ; Zhang G; Wu Y
Wei Sheng Yan Jiu; 2005 Mar; 34(2):187-90. PubMed ID: 15952660
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.
Legrand T; Chhun S; Rey E; Blanchet B; Zahar JR; Lanternier F; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):551-6. PubMed ID: 18848512
[TBL] [Abstract][Full Text] [Related]
16. Determination of theophylline by HPLC and GC-IDMS, the effect of chemically similar xanthine derivatives on the specificity of the method and the possibility of paracetamol as interfering substance.
Kress M; Meissner D; Kaiser P; Hanke R; Wood WG
Clin Lab; 2002; 48(9-10):541-51. PubMed ID: 12389716
[TBL] [Abstract][Full Text] [Related]
17. Determination of amitriptyline and nortriptyline in human liver microsomes with reversed-phase HPLC in vitro.
Shu Y; Zhu RH; Xu ZH; Zhou HH
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):343-6. PubMed ID: 10375781
[TBL] [Abstract][Full Text] [Related]
18. Assay for the simultaneous determination of acetaminophen-caffeine-butalbital in human serum using a monolithic column.
Pistos C; Stewart JT
J Pharm Biomed Anal; 2004 Nov; 36(4):737-41. PubMed ID: 15533665
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk.
Pellegrini M; Marchei E; Rossi S; Vagnarelli F; Durgbanshi A; García-Algar O; Vall O; Pichini S
Rapid Commun Mass Spectrom; 2007; 21(16):2693-703. PubMed ID: 17640086
[TBL] [Abstract][Full Text] [Related]
20. High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma.
Jamali F; Sattari S
J Pharm Pharm Sci; 2000; 3(3):312-7. PubMed ID: 11177649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
